SCHEMBL6171105

SCHEMBL6171105

CC(c1ccnc(-c2ccc(F)cc2)c1)C1NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
MAT2A P31153 1/20 0.38
SCN10A Q9Y5Y9 1/20 0.37
TRPA1 O75762 1/20 0.36
POLB P06746 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
MAPK1 P28482 1/20 0.35
KDM5A P29375 1/20 0.35
KDM2B Q8NHM5 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
HSD11B1 P28845 1/20 0.35
SLC5A1 P13866 4/20 0.34
ATP1A1 P05023 1/20 0.34
ATP1B1 P05026 1/20 0.34
ATP1A3 P13637 1/20 0.34
ATP1B2 P14415 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174756 0.93 MAT2A (0.43) LMNAMAT2ASCN10APOLBL3MBTL1
SCHEMBL6174848 0.92 LMNA (0.46) LMNAMAT2ASCN10APOLBL3MBTL1
SCHEMBL6174788 0.86 LMNA (0.38) LMNAPOLBL3MBTL1SLC5A1LIPE
SCHEMBL6173240 0.85 IGF1R (0.37) LMNATRPA1
SCHEMBL6177752 0.85 IGF1R (0.37) LMNA
SCHEMBL6176756 0.84 LMNA (0.42) LMNAPOLBL3MBTL1ATP1A1ATP1B1
SCHEMBL6173438 0.84 LMNA (0.42) LMNAPOLBL3MBTL1MAPTKDM4E
SCHEMBL6175578 0.84 LMNA (0.42) LMNAPOLBL3MBTL1ATP1A1ATP1B1
SCHEMBL6174656 0.83 LMNA (0.41) LMNAPOLBL3MBTL1SLC5A1ATP1A1
SCHEMBL6172084 0.82 LMNA (0.40) LMNAPOLBL3MBTL1MAPK1SLC5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed